reports
Sýn hf.: Breyting á Fjárhagsdagatali 2024
Sýn hf.: Breyting á Fjárhagsdagatali 2024 Sýn hf. tilkynnir hér með um breytingu á fjárhagsdagatali sem birt var þann 25. janúar 2024. Breytingin lýtur að afkomubirtingu vegna árshlutareiknings 1F 2024, sem færist fram um einn dag og verður 7. maí í stað 8. maí. Fjárfestakynningar munu fara fram í tengslum við birtingu á afkomu 2F og afkomu 4F (ársuppgjörs). Afkoma 4F og ársuppgjör 202327. febrúar 2024Aðalfundur11. apríl 2024Afkoma 1F 20247. maí 2024Afkoma 2F 202428. ágúst 2024Afkoma 3F 20246. nóvember 2024Afkoma 4F og ársuppgjör 202419. febrúar 2025Aðalfundur14. mars 2025 Vinsamlegast athu...
Hilton Grand Vacations Unveils 2024 Brand Ambassadors to Headline Excl...
ORLANDO, Fla.--(BUSINESS WIRE)-- (NYSE:HGV), the premier vacation ownership and experiences company, announces its 2024 Hilton Grand Vacation Brand Ambassadors, including legendary golfer Annika Sörenstam, iconic musician Joey Fatone, singer and actress Katharine McPhee and others. These brand ambassadors will be a central part of the thousands of exclusive private events hosted for HGV members throughout the year, including concerts, sporting events and private chef dinners. HGV is at the forefront of experiential travel, leading the industry in unique offerings and meeting the growing dem...
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Eval...
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024 CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic targeted therapies, today announced that clinical data from its Phase 1 trial of CLN-619 in patients with advanced solid tumors will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting taking place in Chicag...
EQS-News: FCR Immobilien AG: Fristgerechte Rückzahlung 5,25 %-Anleihe ...
EQS-News: FCR Immobilien AG / Schlagwort(e): Anleihe FCR Immobilien AG: Fristgerechte Rückzahlung 5,25 %-Anleihe 2019/2024 24.04.2024 / 16:01 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. FCR Immobilien AG: Fristgerechte Rückzahlung 5,25 %-Anleihe 2019/2024 Pullach im Isartal, 24.04.2024: Die FCR Immobilien AG (“FCR”, ISIN DE000A1YC913) hat mit heutigem Tag den Gesamtbetrag der 5,25 %-Anleihe (WKN: A2TSB1) an das Bankhaus Gebr. Martin AG, vorzeitig überwiesen. Die Ausschüttung erfolgt ab 30.04.2024 seitens der Clearstream Banking...
Juniata Valley Financial Corp. Announces Results for the Quarter Ended...
Juniata Valley Financial Corp. Announces Results for the Quarter Ended March 31, 2024 Mifflintown, PA, April 24, 2024 (GLOBE NEWSWIRE) -- Juniata Valley Financial Corp. (OTCQX:JUVF) (“Juniata”), announced net income for the three months ended March 31, 2024 of $1.4 million, a decrease of 21.8%, compared to net income of $1.7 million for the three months ended March 31, 2023. Earnings per share, basic and diluted, for the three months ended March 31, 2024 was $0.27 compared to $0.35 reported for the three months ended March 31, 2023. President’s Message President and Chief Execu...
Dukhan Bank Q.P.S.C: 1 director
A director at Dukhan Bank Q.P.S.C bought 176,668 shares at 0.000QAR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Qatar National Cement Co: 1 director
A director at Qatar National Cement Co sold 106,000 shares at 0.000QAR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Qatar Electricity & Water Co: 1 director
A director at Qatar Electricity & Water Co bought 92,000 shares at 0.000QAR and the significance rating of the trade was 88/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Regeneron to Showcase Progress in Advancing Novel Investigational Trea...
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO Oral presentation will feature new data for investigational REGN7075, an EGFRxCD28 costimulatory bispecific with the potential to enhance the treatment of certain advanced solid tumors in combination with Libtayo® (cemiplimab-rwlc) 17 presentations to highlight Regeneron's investigational pipeline including checkpoint inhibitors, CD3 bispecifics and CD28 costimulatory bispecifics TARRYTOWN, N.Y., April 24, 2024 (GLOBE NEWSWIRE) -- Reg...
Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/...
Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting Oral presentation of MDNA11’s Phase 1/2 ABILITY-1 Study will feature new and updated clinical data Updated bizaxofusp survival results from the Phase 2b recurrent glioblastoma trial versus propensity matched external control arm will also be presented as a poster TORONTO and HOUSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development...
Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for...
Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting Company to present an update of its ongoing monotherapy and combination Phase 1/1b study of WTX-124 in advanced or metastatic solid tumors WATERTOWN, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatmen...
Coherus Announces Presentation at the 2024 American Society of Clinica...
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting REDWOOD CITY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced the first presentation of clinical data for CHS-114, a highly selective cytolytic anti-CCR8 antibody, at the upcoming ASCO Annual Meeting, which will be held from May 31 to June 4, 2024, at McCormick Place in Chicago. Presentation Details Abstract: 2664Title: Preliminary Results of a Phase 1, First-in-human, Dose Escalation Study of the Anti-CCR8 Cytolytic Anti...
Aktionärinnen und Aktionäre von Cembra stimmen allen Anträgen des Verw...
Cembra Money Bank AG / Schlagwort(e): Generalversammlung Aktionärinnen und Aktionäre von Cembra stimmen allen Anträgen des Verwaltungsrats zu 24.04.2024 / 15:55 CET/CEST Zürich, 24. April 2024 - Die Generalversammlung 2024 der Schweizer Bank Cembra fand heute in Zürich statt. 304 Aktionärinnen und Aktionäre nahmen an der Versammlung teil. Diese vertraten 14'665’422 Namenaktien (einschliesslich durch den unabhängigen Stimmrechtsvertreter vertretene Aktien) respektive 48.88% des ausgegebenen Aktienkapitals. Alle zur Wahl stehenden Mitglieder des Verwaltungsrats wurden für ei...
Cembra shareholders approve all proposals of the Board of Directors
Cembra Money Bank AG / Key word(s): AGMEGM Cembra shareholders approve all proposals of the Board of Directors 24.04.2024 / 15:55 CET/CEST Zurich, 24 April 2024 – The Annual General Meeting 2024 of the Swiss bank Cembra was held in Zurich today. 304 shareholders attended the meeting, representing 14,665,422 registered shares (including the shares represented by the independent proxy) and 48.88% of the issued share capital, respectively. All members of the Board of Directors proposed for re-election were confirmed for a further one-year term of office: Franco Morra (Chairma...
Edison issues initiation on International Public Partnerships (INPP): ...
Edison Investment Research Limited Edison issues initiation on International Public Partnerships (INPP): Consistently and responsibly delivering 24-Apr-2024 / 14:55 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 24 April 2024 Edison issues initiation on International Public Partnerships (INPP): Consistently and responsibly delivering International Public Partnerships’ (INPP’s) FY23 results show that it continues to deliver consistent and predictable returns for investors, while delivering environmental and social benefits for th...
EQS-News: XTPL baut industriellen Prototyp eines Geräts zusammen mit f...
Emittent / Herausgeber: XTPL S.A. / Schlagwort(e): Sonstiges XTPL baut industriellen Prototyp eines Geräts zusammen mit führendem chinesischen Hersteller von Maschinen für die Flachbildschirm-Branche 24.04.2024 / 16:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. XTPL führt derzeit den fünften Verkauf eines Moduls für industrielle Umsetzung durch. Beim Endkunden handelt es sich um einen führenden chinesischen Hersteller von Maschinen für die Flachbildschirm-Branche. Die Geschäftsbeziehung von XTPL mit dem Kunden kam durch die Vermi...
Cue Biopharma to Present at the 2024 American Society of Clinical Onco...
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, announced today that it will present an oral abstract and poster at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 31 – June 4, 2024 in Chicago, IL. The presentations will highlight the Company’s Phase 1 trials of its lead interleukin 2 (IL-2)-based biologics,...
- Stephane Foucaud
Panoro Energy ASA (OSE: PEN): Drilling to restart in EG in June. 70% 2...
• A drilling contract has been awarded for the Noble Venturer drill ship to recommence infill drilling at the Ceiba Field and Okume Complex in June. Owing to limitations arising from the shallower water depth at one of the planned infill well locations, the drilling campaign will now comprise of two infill wells. The third infill well will be deferred as part of a potential future drilling campaign. • This allow production in EG to return to growth. In addition, the rig will then drill the high ...
Neogen Corp: 1 director
A director at Neogen Corp bought 17,477 shares at 12.090USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.